MEDPLUS : BOARD APPROVES BUYBACK WORTH OVER RS 97.5 CR

• Buyback of fully paid equity shares of face value ₹2 each via open market route through stock exchange • Maximum buyback size ₹130.00 Cr at a price not exceeding ₹750 per share, payable in cash • Indicative number of shares to be bought back 17,33,333, representing 1.44% of existing paid-up capital • Company to utilise at least 75% of maximum size, i.e. ₹97.50 Cr minimum buyback size • Promoters and persons in control cannot participate in the buyback; Nuvama Wealth Management appointed manager to the buyback • Promoter holding rises to 40.78% post buyback from 40.19% pre buyback on indicative maximum shares

Medplus Health Services Limited

Open attachment

← Back to feed